NCT05383456 - The Visceral Adiposity Measurement and Observation Study | Biotech Hunter

Enrollment

196

Participants

Timeline

Start Date

April 18, 2022

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions

HIVHIV-InfectionsHIV-1-infectionHIV I InfectionHIV LipodystrophyHIV Infection PrimaryHIV-Associated LipodystrophyHIV Disease ProgressionLipohypertrophyLiver DiseasesNAFLDNASHLiver FibrosisHepatic FibrosisWaist CircumferenceBMIEctopic FatLiver FatHepatic Steatosis

Interventions

DIAGNOSTIC_TEST

Diagnostic Test

Standard diagnostic tests.

DRUG

HIV Anti-retroviral Background Therapy

"All participants are required be on continuous HIV Anti-retroviral Background Therapy.~No intervention on drug is part of the Study."

Trial Locations (8)

10001

AIDS Healthcare Foundation, New York

19107

Fight Community Health Centers, Philadelphia

32806

Bliss Health, Orlando

33133

AIDS Healthcare Foundation, Miami Beach

33140

AIDS Healthcare Foundation, Miami Beach

33308

AIDS Healthcare Foundation, Fort Lauderdale

75208

Prism Health North Texas, Dallas

90036

Ruane Clinical Research, Los Angeles